Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Microbiol Res ; 186-187: 90-8, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27242147

RESUMO

In order to study the regulation of N-acyl-homoserine lactones synthesis (AHLs, the signal molecules of Quorum Sensing regulation) in Burkholderia cenocepacia strain 370 we obtained mutants with increased AHL production. One of the mutants, named BC-B6, was obtained by TnMod-RKm(r) plasposon mutagenesis. The plasposon insertion was located within the clpX gene encoding the ATPase subunit ClpX of the ClpXP protease. The mutation reduced bacterial virulence in mice intranasal infection. The results of proteomic analysis demonstrated that the expression of at least 19 proteins differed not less than 2-fold between the parental and mutant strains. 18 of the proteins were upregulated in the mutant, and one protein was downregulated. The proteins included those that involved in protein synthesis and modification, in energy production, in general metabolism, in transport and regulation. To check the effect of the clpX mutation on the AHL synthesis, a mutant with inactivated clpX gene (BC-clpX:Km(r)) was constructed by gene replacement method. This mutant also exhibited increased AHLs production. A swarming motility of both mutants was reduced compared to the original strain. Thus, the obtained results show that the clpX gene was involved in the regulation of AHL production and a number of cellular processes in B. cenocepacia 370.


Assuntos
Acil-Butirolactonas/metabolismo , Adenosina Trifosfatases/metabolismo , Burkholderia cenocepacia/metabolismo , Mutação , Adenosina Trifosfatases/genética , Animais , Infecções por Burkholderia/microbiologia , Infecções por Burkholderia/patologia , Burkholderia cenocepacia/genética , Modelos Animais de Doenças , Locomoção , Camundongos , Mutagênese Insercional , Proteoma/análise , Fatores de Virulência/genética , Fatores de Virulência/metabolismo
2.
Curr Microbiol ; 53(6): 477-8, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17106799

RESUMO

The antimicrobial activities of commercially available human angiogenin were studied against two pathogens, namely, Candida albicans and Streptococcus pneumoniae. In contrast to the data published earlier, antimicrobial action of angiogenin was rather limited and comparable to that of bovine serum albumin.


Assuntos
Candida albicans/efeitos dos fármacos , Ribonuclease Pancreático/farmacologia , Streptococcus pneumoniae/efeitos dos fármacos , Animais , Anti-Infecciosos , Bovinos , Humanos , Testes de Sensibilidade Microbiana , Soroalbumina Bovina/farmacologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa